A single protein building block commonly found in food may hold a key to preventing the spread of an often-deadly type of breast cancer, according to a new multicenter study published today in the medical journal Nature.
Feb 7, 2018
0
794
Approximately 10 to 15 percent of breast cancer cases do not respond to treatment with hormone therapy, which means that they are more aggressive and often recur. An international research team led by researchers at Lund ...
Mar 12, 2018
0
767
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center ...
Apr 20, 2018
0
443
Researchers at Karolinska Institutet in Sweden have discovered that the risk of death from breast cancer is twice as high for patients with high heterogeneity of the oestrogen receptor within the same tumour as compared to ...
Jan 19, 2018
0
13
Scientists have unveiled clues about a mysterious molecule called Yin Yang1—and revealed it may fuel tumour growth in breast cancer.
Jul 23, 2018
0
158
Scientists have revealed that a key molecule in breast and lung cancer cells can help switch off the cancers' ability to spread around the body.
Mar 21, 2016
0
2213
Jean-François Côté, a researcher at the Montreal Clinical Research Institute (IRCM) and professor at Université de Montréal's Faculty of Medicine, studies metastasis, the leading cause of cancer-related death. Recently, ...
May 7, 2018
0
251
Not so long ago, immunotherapy against cancer was positioned as an emerging or even promising treatment, but not one with a proven track record. Today however, novel immunotherapeutics across different tumor types, either ...
Oct 3, 2018
0
128
Breast cancer spreads to other organs in the body according to certain specific patterns. This has been shown by a team of researchers from Karolinska Institutet and KTH in Sweden and the University of Helsinki in Finland ...
Feb 27, 2018
0
16
The PARP inhibitor, olaparib, that has shown promise in women with an inherited mutation in their BRCA1 or BRCA2 gene (accounting for about 5-10% of breast and ovarian cancer cases), has, for the first time, been shown to ...
Aug 21, 2011
0
1
